The findings from our study underscore the importance of a comprehensive analysis of the tumor microenvironment and immune marker expressions, are consistent with an immunosuppressive tumor microenvironment and raise hypotheses about how FOXP3, PD 1 and CD32B relate to disease progression, but do not establish causal mechanisms. This evidence concerns the gene RPL17 and neoplasm.